Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HJLI | CSBR | ACRV | ||
| Company | Hancock Jaffe Laboratories Inc | Champions Oncolog | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.71 | 6.22 | 2.63 | ||
| High | 10.75 | 7.00 | 2.72 | ||
| Low | 10.26 | 6.22 | 2.51 | ||
| Latest | 10.38 | 6.72 | 2.53 | ||
| Change | -0.21 | +0.42 | -0.08 | ||
| % Change | -1.98% | +6.67% | -3.07% | ||
| Volume | 221,800 | 12,700 | 364,800 | ||
| 20-Day Average Volume | 295,705 | 9,405 | 535,975 | ||
| Previous Close | 10.59 | 6.30 | 2.61 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.16 | 6.43 | 2.39 | ||
| 20-Day Raw Stochastic | 73.54% | 73.08% | 72.60% | ||
| 20-Day Relative Strength | 67.86 | 54.21 | 59.13 | ||
| Weighted Alpha | +9.05 | +9.64 | +6.23 | ||
| Today's Opinion | 88% Buy | 48% Sell | 88% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 40% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.34% since 09/23/21 | +11.26% since 12/05/25 | +6.75% since 12/05/25 | ||
| Low | 9.49 on 09/24/21 | 6.07 on 12/08/25 | 2.38 on 12/08/25 | ||
| High | 11.38 on 09/29/21 | 7.00 on 12/12/25 | 2.73 on 12/11/25 | ||
| 1-Month | |||||
| %Chg | +34.98% since 08/30/21 | -2.18% since 11/12/25 | +10.96% since 11/12/25 | ||
| Low | 7.60 on 09/07/21 | 5.96 on 12/03/25 | 2.00 on 11/14/25 | ||
| High | 11.38 on 09/29/21 | 7.00 on 12/12/25 | 2.73 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | +51.09% since 06/30/21 | -1.61% since 09/12/25 | +66.45% since 09/12/25 | ||
| Low | 5.36 on 07/19/21 | 5.96 on 12/03/25 | 1.47 on 09/15/25 | ||
| High | 11.38 on 09/29/21 | 8.74 on 09/15/25 | 2.73 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | +62.70% since 03/30/21 | -9.07% since 06/12/25 | +99.21% since 06/12/25 | ||
| Low | 4.99 on 05/13/21 | 5.85 on 08/01/25 | 1.15 on 07/01/25 | ||
| High | 11.38 on 09/29/21 | 9.63 on 07/09/25 | 2.73 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,146 | 92,581 | 79,834 | ||
| Shares Outstanding, K | 8,685 | 13,777 | 31,555 | ||
| Annual Sales | 0 | 56,940,000 | 0 | ||
| Annual Net Income | -9,140,000 | 4,700,000 | -80,560,000 | ||
| Last Quarter Sales | 0 | 14,000,000 | 0 | ||
| Last Quarter Net Income | -2,380,000 | -440,000 | -18,230,000 | ||
| 60-Month Beta | 1.51 | 0.35 | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.03 on 09/15/25 | -0.47 on 11/13/25 | ||
| Latest Earnings Date | 11/16/21 | 12/15/25 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.50 | 0.00 | ||